Incyclix Bio

Incyclix Bio is a clinical stage pharmaceutical company developing small molecule inhibitors of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant cancers. The team’s unique insights about the biology and structure of CDKs will facilitate the rapid discovery and development of a novel, potent, and selective CDK2 inhibitor to treat patients whose tumors are insensitive to CDK4/6 inhibition.

Jupiter Bioventures builds breakthrough biotech companies from the ground up, partnering with the world’s leading biologists and physicians.

Engineering targeted growth factors.

Envisioning a new way for company formation and venture growth in transformative medicines.

Pacegenix

Transforming the future of arrhythmia therapeutics.

Next generation precision genome editing.

Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing first-in-class RSK kinase inhibitors as a targeted therapy for cancer.

Working with governments, international agencies, and private sector partners, Med Aditus seeks to revolutionize access to medicine in Sub-Saharan Africa, from product development and manufacturing to secure supply chains and patient delivery to provide healthier and longer life though better access to medicines.

Sapience is a clinical stage biotech company pioneering a new class of peptide antagonists. Sapience has two compounds in the clinic: ST101 a CEBP beta inhibitor for GBM, and ST316 a beta catenin inhibitor for colorectal cancer.

An operating private equity fund that in-licenses drug candidates and develops through late-stage for ultimate sale to a commercializing company.

Aruna Bio is advancing a new class of cell-free biologics, exosomes, for the treatment of neurodegenerative disorders and leveraging a novel platform to optimize the delivery of RNAs, antibodies, genes and small molecules.

Developing "on demand" pharmaceuticals to restore voluntary control of bladder and bowel for people with spinal cord injury and neurological conditions.

Carbon® is a 3D printing technology company helping businesses to develop better products and bring them to market in less time. Carbon is a venture-backed company headquartered in Redwood City, CA.